#GreatDebate #ACR23 @RheumNow Advanced Rx 1st line in PMR/GCA @philseo IL-6 research in RA (STREAM, MOBILITY): safety
Tweet Content
#GreatDebate #ACR23 @RheumNow
Advanced Rx 1st line in PMR/GCA
@philseo
IL-6 research in RA (STREAM, MOBILITY): safety of toci, sarilumab - compares to ADA
Ifn risk driven by GCs
GUSTO: TCZ w/ only 3d GC pulse - 13/18 in remission 24, 52w
PMR: "its not just a little bit of pred" https://t.co/sAlQ0pttcq
Show on Archive Page
On
Display in Search Results
On
PDQ
Off